| John V Thomas, MD | |
|
619 19th St S, Birmingham, AL 35249-1900 | |
| (205) 934-4011 | |
| Not Available |
| Full Name | John V Thomas |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 38 Years |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790871796 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 2000-00149 (North Carolina) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 68784 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital Rochester | Rochester, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic | 6507778255 | 4232 |
News Archive
Schools are taking a proactive approach to get students to move more and improve their eating habits. But it takes a team effort at both school and home to make a difference, said Greg Welk, a professor of kinesiology at Iowa State University.
Federal efforts to combat health care fraud recovered a record $4.3 billion in fiscal 2013 and have recouped more than $8 for every $1 spent on enforcement over the past three years, according to an annual report released Wednesday.
Lorus Therapeutics has announced that the EMEA (European Medicines Agency) has given a positive opinion on Lorus' application for orphan drug status to Virulizin, the company's lead anticancer drug for the treatment of pancreatic cancer.
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).
President Obama is hoping to give a boost to congressional Democrats who are reconvening after a recess beleaguered by harsh criticism, plummeting public opinion, and divisions within the majority party.
› Verified 5 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
Schools are taking a proactive approach to get students to move more and improve their eating habits. But it takes a team effort at both school and home to make a difference, said Greg Welk, a professor of kinesiology at Iowa State University.
Federal efforts to combat health care fraud recovered a record $4.3 billion in fiscal 2013 and have recouped more than $8 for every $1 spent on enforcement over the past three years, according to an annual report released Wednesday.
Lorus Therapeutics has announced that the EMEA (European Medicines Agency) has given a positive opinion on Lorus' application for orphan drug status to Virulizin, the company's lead anticancer drug for the treatment of pancreatic cancer.
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).
President Obama is hoping to give a boost to congressional Democrats who are reconvening after a recess beleaguered by harsh criticism, plummeting public opinion, and divisions within the majority party.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-lake City |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164463659 PECOS PAC ID: 1951213487 Enrollment ID: O20031104000095 |
News Archive
Schools are taking a proactive approach to get students to move more and improve their eating habits. But it takes a team effort at both school and home to make a difference, said Greg Welk, a professor of kinesiology at Iowa State University.
Federal efforts to combat health care fraud recovered a record $4.3 billion in fiscal 2013 and have recouped more than $8 for every $1 spent on enforcement over the past three years, according to an annual report released Wednesday.
Lorus Therapeutics has announced that the EMEA (European Medicines Agency) has given a positive opinion on Lorus' application for orphan drug status to Virulizin, the company's lead anticancer drug for the treatment of pancreatic cancer.
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).
President Obama is hoping to give a boost to congressional Democrats who are reconvening after a recess beleaguered by harsh criticism, plummeting public opinion, and divisions within the majority party.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891701637 PECOS PAC ID: 4385556703 Enrollment ID: O20031104000408 |
News Archive
Schools are taking a proactive approach to get students to move more and improve their eating habits. But it takes a team effort at both school and home to make a difference, said Greg Welk, a professor of kinesiology at Iowa State University.
Federal efforts to combat health care fraud recovered a record $4.3 billion in fiscal 2013 and have recouped more than $8 for every $1 spent on enforcement over the past three years, according to an annual report released Wednesday.
Lorus Therapeutics has announced that the EMEA (European Medicines Agency) has given a positive opinion on Lorus' application for orphan drug status to Virulizin, the company's lead anticancer drug for the treatment of pancreatic cancer.
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).
President Obama is hoping to give a boost to congressional Democrats who are reconvening after a recess beleaguered by harsh criticism, plummeting public opinion, and divisions within the majority party.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
Schools are taking a proactive approach to get students to move more and improve their eating habits. But it takes a team effort at both school and home to make a difference, said Greg Welk, a professor of kinesiology at Iowa State University.
Federal efforts to combat health care fraud recovered a record $4.3 billion in fiscal 2013 and have recouped more than $8 for every $1 spent on enforcement over the past three years, according to an annual report released Wednesday.
Lorus Therapeutics has announced that the EMEA (European Medicines Agency) has given a positive opinion on Lorus' application for orphan drug status to Virulizin, the company's lead anticancer drug for the treatment of pancreatic cancer.
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).
President Obama is hoping to give a boost to congressional Democrats who are reconvening after a recess beleaguered by harsh criticism, plummeting public opinion, and divisions within the majority party.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-fairmont |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366410862 PECOS PAC ID: 4981694981 Enrollment ID: O20040719000142 |
News Archive
Schools are taking a proactive approach to get students to move more and improve their eating habits. But it takes a team effort at both school and home to make a difference, said Greg Welk, a professor of kinesiology at Iowa State University.
Federal efforts to combat health care fraud recovered a record $4.3 billion in fiscal 2013 and have recouped more than $8 for every $1 spent on enforcement over the past three years, according to an annual report released Wednesday.
Lorus Therapeutics has announced that the EMEA (European Medicines Agency) has given a positive opinion on Lorus' application for orphan drug status to Virulizin, the company's lead anticancer drug for the treatment of pancreatic cancer.
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).
President Obama is hoping to give a boost to congressional Democrats who are reconvening after a recess beleaguered by harsh criticism, plummeting public opinion, and divisions within the majority party.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System St James |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023177730 PECOS PAC ID: 9537170352 Enrollment ID: O20060509000021 |
News Archive
Schools are taking a proactive approach to get students to move more and improve their eating habits. But it takes a team effort at both school and home to make a difference, said Greg Welk, a professor of kinesiology at Iowa State University.
Federal efforts to combat health care fraud recovered a record $4.3 billion in fiscal 2013 and have recouped more than $8 for every $1 spent on enforcement over the past three years, according to an annual report released Wednesday.
Lorus Therapeutics has announced that the EMEA (European Medicines Agency) has given a positive opinion on Lorus' application for orphan drug status to Virulizin, the company's lead anticancer drug for the treatment of pancreatic cancer.
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).
President Obama is hoping to give a boost to congressional Democrats who are reconvening after a recess beleaguered by harsh criticism, plummeting public opinion, and divisions within the majority party.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John V Thomas, MD 200 1st St Sw, Rochester, MN 55905-0002 Ph: (507) 284-2511 | John V Thomas, MD 619 19th St S, Birmingham, AL 35249-1900 Ph: (205) 934-4011 |
News Archive
Schools are taking a proactive approach to get students to move more and improve their eating habits. But it takes a team effort at both school and home to make a difference, said Greg Welk, a professor of kinesiology at Iowa State University.
Federal efforts to combat health care fraud recovered a record $4.3 billion in fiscal 2013 and have recouped more than $8 for every $1 spent on enforcement over the past three years, according to an annual report released Wednesday.
Lorus Therapeutics has announced that the EMEA (European Medicines Agency) has given a positive opinion on Lorus' application for orphan drug status to Virulizin, the company's lead anticancer drug for the treatment of pancreatic cancer.
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).
President Obama is hoping to give a boost to congressional Democrats who are reconvening after a recess beleaguered by harsh criticism, plummeting public opinion, and divisions within the majority party.
› Verified 5 days ago
Dr. Garrett Colby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Jt N342, Birmingham, AL 35249 Phone: 205-934-3108 Fax: 205-975-4413 | |
Drexell H Boggs, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233 Phone: 205-975-9399 Fax: 205-975-5184 | |
James Walker, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Joseph Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Michelle M Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Sharda Mehar Bajaj, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1526 5th Ave S, Birmingham, AL 35233 Phone: 205-279-2860 | |
Gina Elizabeth Rebesco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-975-0222 |